Tenderwize
Zurück zur Suche

Lanthanum Carbonate Chewable Tablets

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline May 30, 2028 · 644 days left·Open·Supplies
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Lanthan(III)-carbonat (ATC: V03AE03 - in der Darreichungsform Kautabletten)

61/100

Opportunity Score

PromisingMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

61 / 100

Komplexität

42 / 100

Risikofaktoren

The structured deadline/fallback date (30.05.2028 22:00) differs from the XML end date/occurrence date (31.05.2028 00:0...

Structured data says electronicSubmission = not-allowed, while the XML text says contract documents may be sent by emai...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Strong opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply / rebate agreement for pharmaceutical products containing lanthanum(III)-carbonate in chewable tablet form.
  • Open-house model with uniform contract terms and equal access for interested pharmaceutical companies.
Vollständige Zusammenfassung anzeigen

This is an open-house style pharmaceutical supply notice by AOK Sachsen-Anhalt for non-exclusive rebate agreements on lanthanum(III) carbonate chewable tablets (ATC V03AE03). The contract can be joined at any time on the same terms, with no individual negotiations, and the term runs until 31.07.2028. The notice provides a document URL and explicitly allows submission of signed contract documents by email or post, but the procedure is described as not a public contract under GWB despite being published in TED.

Risiken

The structured deadline/fallback date (30.05.2028 22:00) differs from the XML end date/occurrence date (31.05.2028 00:0...

Structured data says electronicSubmission = not-allowed, while the XML text says contract documents may be sent by emai...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Administrative

  • Interested pharmaceutical companies must request the participation documents and the contract from the contact address.
  • The participation documents must be fully completed and signed.
  • The notice states that the contract documents may be submitted either by post or electronically as a PDF with a qualified electronic signature.

Auftraggeber

Ort

Magdeburg, DEU

Auftraggeberprofil

Profil öffnen

Kennung

DE258393558

Tätigkeit

Health

Lose (1)

LOT-0001

Lanthanum Carbonate Chewable Tablets

Non-exclusive rebate agreement for finished medicinal products containing lanthanum(III) carbonate (ATC V03AE03) in chewable tablet form. The open-house model means any eligible pharmaceutical company may join at any time under uniform terms; no exclusivity and no individual negotiations. This lot information is taken from structured data and the notice text.

SuppliesEU fundedElectronic submission

Ort

DEE03, Germany

Dauer

2 YEAR

Kategorie

Pharmaceutical products

Frist

Deadline May 30, 2028

Vergabedetails

Veröffentlichungsdatum
08 Jun 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
394434-2026

Dokumente (1)

Ähnliche Ausschreibungen